[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-345203-105":59,"doc-detail-345203-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","discovery-of-thieno32-cpyran-based-leads-for-liver-lung-and-glioma-cancer-synthesis-dockingguided-optimization-and-apoptotic-profiling","Discovery of thieno[3,2-c]pyran-based leads for liver, lung and glioma cancer: synthesis, dockingguided optimization and apoptotic proﬁling","","Thieno[3,2-c]pyran was used to design substituted derivatives evaluated for anticancer activity against HepG2 and A549 cell lines. In vitro cytotoxicity assays identified promising IC50 values, while apoptosis-induction studies supported the compounds’ anticancer potential. Selected molecules showed specific binding affinities in molecular docking, and further testing included non-cancerous HEK293 cells and EGFR-inhibition on a glioma model to confirm a proposed pathway. Compounds 5a, 5e, and 5n are suggested as lead candidates for targeted therapy development.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/discovery-of-thieno32-cpyran-based-leads-for-liver-lung-and-glioma-cancer-synthesis-dockingguided-optimization-and-apoptotic-profiling/345203/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/discovery-of-thieno32-cpyran-based-leads-for-liver-lung-and-glioma-cancer-synthesis-dockingguided-optimization-and-apoptotic-profiling/345203.png","ImageObject",300,407,{"name":92,"@type":93},"Aria","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What compounds were synthesized and evaluated in this study?","Question",{"text":112,"@type":113},"A series of substituted thieno[3,2-c]pyran derivatives were synthesized and evaluated against HepG2 and A549 cell lines.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was anticancer activity assessed?",{"text":117,"@type":113},"Cytotoxicity was measured using in vitro assays, and apoptosis induction was studied to confirm anticancer potential.",{"name":119,"@type":110,"acceptedAnswer":120},"What evidence supports the proposed mechanism?",{"text":121,"@type":113},"Molecular docking identified binding affinities, and selected compounds were tested against EGFR-overexpressed glioma cells to confirm EGFR inhibition and the proposed pathway.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},345203,1790131997,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},2336464648322,"https://ap-avatar.wpscdn.com/avatar/2200025388227c56fec?_k=1778556882303663488","RSC Advances  \nPAPER  \nCite this: RSC Adv., 2026, 16, 20330  \nReceived 3rd December 2025 Accepted 6th April 2026  \nDOI: 10.1039/d5ra09341d[rsc.li/rsc-advances](rsc.li/rsc-advances)  \nDiscovery of thieno[3,2-c]pyran-based leads for liver, lung and glioma cancer: synthesis, dockingguided optimization and apoptotic proﬁling  \nAbhishek Jauhari,a Pooja,b Lakshay Taneja,c Ajay Kumar Yadav,c Ismail Althagaﬁ,d Ramendra Pratap  *e and Dharmendra Kumar Yadav  *f  \nThieno[3,2-c]pyran is a versatile heterocyclic framework recognised as a core scaﬀold in numerous synthetic anticancer agents and naturally occurring alkaloids exhibiting potent antitumor activity across various malignancies, including lung, liver, breast, and prostate cancers. In this study, we report the synthesis of a series of substituted thieno[3,2-c]pyran derivatives and their biological evaluation against human hepatocellular carcinoma (HepG2) and lung adenocarcinoma (A549) cell lines. The in vitro cytotoxicity assays revealed promising IC50 values: 5a exhibited 13 .65 ± 0.32 mM (HepG2) and 12 .35 ± 0.30 mM (A549), while 5n showed 13 .26 ± 0.32 mM (HepG2) and 12 .36 ± 0.30 mM (A549) . Apoptosisinduction studies conﬁrmed the anticancer potential of these compounds. However, compound 5e works well against Glioma cancer with a promising IC50 value of 26 mM (LN229) . We have also performed the testing of selected compounds against the non-cancerous cell line HEK293 under the same conditions and concentration, and no cytotoxicity. Among the synthesized compounds, 5a and 5n demonstrated signiﬁcant binding aﬃnities in molecular docking studies, with docking scores of −8.834 and −8. 994 kcal mol −1 against liver cancer targets, and −7. 925 and −7. 871 kcal mol −1 against lung cancer targets, respectively. To further conﬁrm the EGFR inhibition, selected compounds were tested agaist EGFR overexpressed glioma cell line, and good cytotoxicity conﬁrms the proposed pathway. These ﬁndings suggest that compounds 5a, 5e and 5n warrant further investigation as lead molecules for the development of targeted therapies for liver, glioma and lung cancers.  \n1 Introduction  \nCancer, characterized by the abnormal growth of cells in the body, is a major global health concern. According to the American Cancer Society (ACS), it is estimated that cancer causes approximately 1700 deaths daily, contributing to around 15% of all human deaths worldwide. Cancer cells o􀀁en evade apoptosis, leading to unchecked growth and angiogenesis—hallmarks of all cancer types.1–4 Apoptosis is essential for preventing cancer, and targeting this process is a highly eﬀective cancer treatment strategy. Many anticancer drugs focus on various stages of the intrinsic and extrinsic apoptotic pathways.5,6  \naDepartment of Neurological Surgery, University of Pittsburgh, 15213, USA bDepartment of Chemistry, Sri Venkateshwara College, Delhi, 110021, India  \ncDr B. R. Ambedkar Center for Biomedical Research, University of Delhi, North Campus, Delhi, 110007, India  \ndDepartment of Chemistry, Faculty of Science, Umm Al-Qura University, Makkah, 21955, Saudi Arabia  \neDepartment of Chemistry, University of Delhi, North Campus, Delhi, 110007, India.  \nE-mail: [rpratap@chemistry.du.ac.in](rpratap@chemistry.du.ac.in); [ramendrapratap@gmail.com](ramendrapratap@gmail.com)  \nfDepartment of Biologics, College of Pharmacy, Gachon University, Hambakmoeiro 191, Yeonsu-gu, Incheon 21924, Republic of Korea  \nLung cancer is one of the most prevalent cancers, with the highest rates of morbidity and mortality globally. Despite existing chemotherapeutic treatments, many are inadequate due to serious side eﬀects and drug resistance.7 Therefore, developing safe and eﬀective new treatments for lung cancer is critical. According to global cancer statistics from 2018, lung cancer accounts for 11.6% of all diagnosed cancer cases and is the leading cause of cancer death, responsible for 18.4% of all cancer-related deaths. Lung cancer is primarily classi􀀁e","cbCaifFCdaeQnP4D","https://ap.wps.com/l/cbCaifFCdaeQnP4D","pdf",1614849,"English","# Introduction\n## Cancer and apoptosis targeting\n## Lung cancer background and therapeutic challenges\n## Thienopyran and fused pyran anticancer scaffolds\n## Prior pyran/chromene analogs and rationale","[{\"question\":\"What compounds were synthesized and evaluated in this study?\",\"answer\":\"A series of substituted thieno[3,2-c]pyran derivatives were synthesized and evaluated against HepG2 and A549 cell lines.\"},{\"question\":\"How was anticancer activity assessed?\",\"answer\":\"Cytotoxicity was measured using in vitro assays, and apoptosis induction was studied to confirm anticancer potential.\"},{\"question\":\"What evidence supports the proposed mechanism?\",\"answer\":\"Molecular docking identified binding affinities, and selected compounds were tested against EGFR-overexpressed glioma cells to confirm EGFR inhibition and the proposed pathway.\"}]","Discovery of thieno[3,2-c]pyran-based leads for liver, lung and glioma cancer: synthesis, dockingguided optimization and apoptotic proﬁling | PDF",1790056775,25,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9c900fbd5e0917a78feeb849eee58f03.webp",983,1287,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/53ff887cf8fdc51c9ee438229a331906.webp",982,1286,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d3fa103b4283b6b573b59602da397d28.webp",981,1284,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/602eab6e62d3864d0bba97f7b2ef3b0e.webp",980,1283]